rete ovarii adenocarcinoma

Rete ovarii adenocarcinoma is an exceptionally rare type of cancer that arises from the rete ovarii, a network of cellular cords and tubes located in the ovarian hilus [1]. It is considered a subtype of ovarian carcinoma.

The rete ovarii is a vestigial structure present in the ovarian hilus that is histologically identical to its testicular homologue [11]. Rete ovarii adenocarcinoma typically presents as a large tumor, and it can be difficult to differentiate from other types of ovarian tumors, such as retiform Sertoli-Leydig cell tumors (RSLCT) [15].

The immunophenotype of rete ovarii adenocarcinoma is similar to that of the rete ovarii and overlaps between that of an epithelial tumor and a sex cord-stromal tumor [5]. This rare cancer is often associated with a poor prognosis.

It's worth noting that rete ovarii adenocarcinoma is one of the rarest forms of ovarian cancer, and more research is needed to fully understand its characteristics and behavior.

Rete ovarii adenocarcinoma is a rare type of ovarian cancer that can cause various signs and symptoms. According to the search results, the most common symptoms include:

• Abdominal discomfort and pressure [14]
• Virilization (development of male characteristics in females) [14]
• Hirsutism (excessive hair growth on the body) [14]
• Pelvic mass (a lump or tumor in the pelvic area) [14]

In one reported case, a 52-year-old woman presented with abdominal swelling and ascites (fluid accumulation in the abdomen) [14]. It's essential to note that these symptoms can be similar to those of other ovarian cancers, making it crucial for accurate diagnosis.

It's also worth mentioning that rete ovarii adenocarcinoma is a rare phenomenon, and its presentation may vary from person to person. If you or someone you know is experiencing any of these symptoms, it's essential to consult with a healthcare professional for proper evaluation and treatment.

References: [14]

Diagnostic Tests for Rete Ovarii Adenocarcinoma

Rete ovarii adenocarcinoma, a rare and aggressive type of ovarian cancer, requires prompt diagnosis to ensure effective treatment. The following diagnostic tests are commonly used to detect this condition:

• Imaging tests: Transvaginal ultrasound (TVS) and computed tomography (CT) scans may be performed to visualize the ovaries and surrounding tissues. These tests can help identify any abnormalities or tumors in the ovaries [7].
• Blood tests: A blood test to measure CA-125 levels may be conducted, as elevated levels of this protein are often associated with ovarian cancer, including rete ovarii adenocarcinoma [12][13]. However, it's essential to note that a high CA-125 level can also indicate other conditions.
• Pelvic exam: A pelvic exam by a healthcare provider may be performed to check for any abnormalities in the external genitalia, vagina, and cervix [1].
• Biopsy: A biopsy of the affected tissue or tumor may be taken during surgery to confirm the diagnosis. The pathologist will examine the sample under a microscope to determine the type of cancer and its characteristics [4].

It's worth noting that rete ovarii adenocarcinoma is a rare condition, and these diagnostic tests may not always detect it. A combination of imaging tests, blood tests, and surgical biopsy may be necessary to confirm the diagnosis.

References:

[1] Context result 1 [7] Context result 7 [12] Context result 12 [13] Context result 13

Based on the provided context, it appears that rete ovarii adenocarcinoma is a rare manifestation of adenocarcinoma of rete ovarii.

The treatment for rete ovarii adenocarcinoma typically involves surgical excision of the tumor. According to search result [10], surgical excision showed progression-free survival and overall survival, indicating that surgery can be an effective treatment option for this condition.

In addition to surgery, oncologic treatment may also be indicated for adenocarcinomas, including rete ovarii adenocarcinoma (search result [10]).

It's worth noting that chemotherapy is a common treatment for various types of cancer, including ovarian cancer. However, there is limited information in the provided context regarding the use of chemotherapy specifically for rete ovarii adenocarcinoma.

Therefore, based on the available information, the drug treatment for rete ovarii adenocarcinoma typically involves surgical excision and possibly oncologic treatment, with limited information on the use of chemotherapy.